vs
Krystal Biotech, Inc.（KRYS）与REPUBLIC BANCORP INC（RBCAA）财务数据对比。点击上方公司名可切换其他公司
Krystal Biotech, Inc.的季度营收约是REPUBLIC BANCORP INC的1.1倍（$107.1M vs $94.3M），Krystal Biotech, Inc.净利率更高（48.0% vs 24.2%，领先23.8%），Krystal Biotech, Inc.同比增速更快（17.5% vs 5.3%），REPUBLIC BANCORP INC自由现金流更多（$161.1M vs $75.4M），过去两年Krystal Biotech, Inc.的营收复合增速更高（53.8% vs -11.5%）
Krystal Biotech是一家处于临床阶段的生物技术企业，专注于研发和商业化针对罕见重症皮肤病的新型基因疗法，主要面向北美和欧洲市场，服务缺乏有效常规治疗方案的单基因皮肤病患者。
肯塔基州共和银行是美国的一家区域性银行控股企业，提供零售及商业银行全品类服务，涵盖个人存贷款、企业融资、按揭产品及财富管理解决方案，主要服务肯塔基州及周边州的个人消费者和中小企业客户。
KRYS vs RBCAA — 直观对比
营收规模更大
KRYS
是对方的1.1倍
$94.3M
营收增速更快
KRYS
高出12.2%
5.3%
净利率更高
KRYS
高出23.8%
24.2%
自由现金流更多
RBCAA
多$85.7M
$75.4M
两年增速更快
KRYS
近两年复合增速
-11.5%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $107.1M | $94.3M |
| 净利润 | $51.4M | $22.8M |
| 毛利率 | — | — |
| 营业利润率 | 41.5% | 29.3% |
| 净利率 | 48.0% | 24.2% |
| 营收同比 | 17.5% | 5.3% |
| 净利润同比 | 13.0% | 20.0% |
| 每股收益（稀释后） | $1.69 | — |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收KRYSRBCAA
| Q4 25 | $107.1M | $94.3M | ||
| Q3 25 | $97.8M | $93.5M | ||
| Q2 25 | $96.0M | $93.8M | ||
| Q1 25 | $88.2M | $135.8M | ||
| Q4 24 | $91.1M | $89.5M | ||
| Q3 24 | $83.8M | $88.1M | ||
| Q2 24 | $70.3M | $86.9M | ||
| Q1 24 | $45.3M | $120.3M |
净利润KRYSRBCAA
| Q4 25 | $51.4M | $22.8M | ||
| Q3 25 | $79.4M | $29.7M | ||
| Q2 25 | $38.3M | $31.5M | ||
| Q1 25 | $35.7M | $47.3M | ||
| Q4 24 | $45.5M | $19.0M | ||
| Q3 24 | $27.2M | $26.5M | ||
| Q2 24 | $15.6M | $25.2M | ||
| Q1 24 | $932.0K | $30.6M |
营业利润率KRYSRBCAA
| Q4 25 | 41.5% | 29.3% | ||
| Q3 25 | 42.3% | 40.4% | ||
| Q2 25 | 40.9% | 43.0% | ||
| Q1 25 | 41.0% | 44.1% | ||
| Q4 24 | 45.4% | 25.8% | ||
| Q3 24 | 26.8% | 38.4% | ||
| Q2 24 | 12.2% | 37.0% | ||
| Q1 24 | -14.8% | 32.2% |
净利率KRYSRBCAA
| Q4 25 | 48.0% | 24.2% | ||
| Q3 25 | 81.2% | 31.8% | ||
| Q2 25 | 39.9% | 33.5% | ||
| Q1 25 | 40.5% | 34.8% | ||
| Q4 24 | 49.9% | 21.2% | ||
| Q3 24 | 32.4% | 30.1% | ||
| Q2 24 | 22.2% | 29.0% | ||
| Q1 24 | 2.1% | 25.4% |
每股收益（稀释后）KRYSRBCAA
| Q4 25 | $1.69 | — | ||
| Q3 25 | $2.66 | — | ||
| Q2 25 | $1.29 | — | ||
| Q1 25 | $1.20 | — | ||
| Q4 24 | $1.53 | — | ||
| Q3 24 | $0.91 | — | ||
| Q2 24 | $0.53 | — | ||
| Q1 24 | $0.03 | — |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $496.3M | $220.0M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $1.2B | $1.1B |
| 总资产 | $1.3B | $7.0B |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资KRYSRBCAA
| Q4 25 | $496.3M | $220.0M | ||
| Q3 25 | $392.6M | $484.2M | ||
| Q2 25 | $353.8M | $484.8M | ||
| Q1 25 | $308.8M | $793.0M | ||
| Q4 24 | $344.9M | $432.2M | ||
| Q3 24 | $374.0M | $530.9M | ||
| Q2 24 | $345.8M | $400.1M | ||
| Q1 24 | $359.0M | $546.4M |
股东权益KRYSRBCAA
| Q4 25 | $1.2B | $1.1B | ||
| Q3 25 | $1.1B | $1.1B | ||
| Q2 25 | $1.0B | $1.1B | ||
| Q1 25 | $984.7M | $1.0B | ||
| Q4 24 | $946.4M | $992.0M | ||
| Q3 24 | $885.8M | $979.7M | ||
| Q2 24 | $838.9M | $955.4M | ||
| Q1 24 | $799.2M | $935.6M |
总资产KRYSRBCAA
| Q4 25 | $1.3B | $7.0B | ||
| Q3 25 | $1.2B | $7.0B | ||
| Q2 25 | $1.1B | $7.0B | ||
| Q1 25 | $1.1B | $7.1B | ||
| Q4 24 | $1.1B | $6.8B | ||
| Q3 24 | $982.3M | $6.7B | ||
| Q2 24 | $917.7M | $6.6B | ||
| Q1 24 | $853.3M | $6.9B |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $77.5M | $168.2M |
| 自由现金流经营现金流 - 资本支出 | $75.4M | $161.1M |
| 自由现金流率自由现金流/营收 | 70.4% | 170.9% |
| 资本支出强度资本支出/营收 | 2.0% | 7.5% |
| 现金转化率经营现金流/净利润 | 1.51× | 7.37× |
| 过去12个月自由现金流最近4个季度 | $188.9M | $288.6M |
8季度趋势，按日历期对齐
经营现金流KRYSRBCAA
| Q4 25 | $77.5M | $168.2M | ||
| Q3 25 | $39.7M | $33.3M | ||
| Q2 25 | $52.7M | $8.4M | ||
| Q1 25 | $31.0M | $93.2M | ||
| Q4 24 | $52.8M | $149.0M | ||
| Q3 24 | $58.9M | $51.3M | ||
| Q2 24 | $-4.2M | $4.0M | ||
| Q1 24 | $15.9M | $71.2M |
自由现金流KRYSRBCAA
| Q4 25 | $75.4M | $161.1M | ||
| Q3 25 | $38.0M | $30.8M | ||
| Q2 25 | $50.8M | $5.2M | ||
| Q1 25 | $24.8M | $91.6M | ||
| Q4 24 | $52.0M | $143.2M | ||
| Q3 24 | $57.8M | $49.8M | ||
| Q2 24 | $-5.3M | $2.7M | ||
| Q1 24 | $14.6M | $69.1M |
自由现金流率KRYSRBCAA
| Q4 25 | 70.4% | 170.9% | ||
| Q3 25 | 38.8% | 32.9% | ||
| Q2 25 | 52.9% | 5.5% | ||
| Q1 25 | 28.1% | 67.4% | ||
| Q4 24 | 57.1% | 160.0% | ||
| Q3 24 | 69.0% | 56.5% | ||
| Q2 24 | -7.5% | 3.1% | ||
| Q1 24 | 32.3% | 57.5% |
资本支出强度KRYSRBCAA
| Q4 25 | 2.0% | 7.5% | ||
| Q3 25 | 1.7% | 2.6% | ||
| Q2 25 | 2.0% | 3.5% | ||
| Q1 25 | 7.0% | 1.2% | ||
| Q4 24 | 0.9% | 6.5% | ||
| Q3 24 | 1.2% | 1.7% | ||
| Q2 24 | 1.6% | 1.5% | ||
| Q1 24 | 2.8% | 1.7% |
现金转化率KRYSRBCAA
| Q4 25 | 1.51× | 7.37× | ||
| Q3 25 | 0.50× | 1.12× | ||
| Q2 25 | 1.38× | 0.27× | ||
| Q1 25 | 0.87× | 1.97× | ||
| Q4 24 | 1.16× | 7.84× | ||
| Q3 24 | 2.17× | 1.93× | ||
| Q2 24 | -0.27× | 0.16× | ||
| Q1 24 | 17.05× | 2.33× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
